TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
Clinical trial NCT02608411 · TERMINATED
Trial details
- NCT number
- NCT02608411
- Sponsor
- Istituto Oncologico Veneto IRCCS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-19
- Primary completion
- 2017-02-21
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.